Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. sophomore Avg
|
New words:
add, advertising, advice, Advisory, affirmative, ahead, Alabama, alleged, analog, Apex, arm, assert, ATOMIC, bank, begun, bring, Burkholderia, cessation, children, Clark, Combivir, committed, complement, conform, convened, cure, cured, customary, cycle, daclatasvir, denied, dismissal, dismissed, ELECTRON, EMA, employment, Eurodollar, evidence, experimental, expert, Fremont, fully, genotype, grew, guarantee, half, hand, HBV, HCV, herewith, Idenix, inclusive, incomplete, installment, integrated, intervention, inventor, inventorship, isolation, Jeremy, judge, leukemia, Lipitor, living, lymphocytic, MD, motion, nucleotide, null, opportunity, owner, panel, pattern, PDUFA, pediatric, percent, pharmasset, powder, premium, PrEP, prioritizing, progression, prohibition, prosecutor, QUANTUM, Raymond, reallocate, reconsideration, relapse, revascularization, rollforward, Roy, Schinazi, shortage, shortly, showed, smaller, sNDA, sovereign, spent, stay, Submission, successor, swing, tender, timeline, track, Turkey, uninfected, unvested, Valeant, void, volatility, yield, zidovudine
Removed:
AAA, achievement, Addendum, advanced, aeruginosa, allocated, Alto, antibody, APIC, arisen, Arroyo, attributed, austerity, autoimmune, award, banker, began, calculating, cancer, cardiovascular, CGI, charged, cidofovir, closing, Code, commenced, commencing, Comparatively, Cougar, coupon, dated, declined, delta, desire, deterioration, diagnosing, dosage, downgrade, drawn, Extensible, Eyetech, Family, fibrotic, focused, formation, formatted, fungal, furnished, geographic, GS, GSL, hematological, humanized, iii, imaging, implemented, Incentive, Indemnity, inducement, inflammatory, infrastructure, infrequently, intent, interpretation, isoform, iv, kinase, LIBOR, liposome, liquidate, location, lysyl, mAb, Medicine, mg, mission, monoclonal, Moody, myocardial, obligated, observing, occurrence, oseltamivir, PAH, Palo, par, partner, perfusion, pertaining, pharmacologic, pharmacological, phosphate, preferentially, prevention, professional, protease, protein, quickly, radionuclide, rated, reach, redeem, redeemed, redemption, reduction, regadenoson, renew, retained, School, science, Seattle, selectively, semiannual, Sequentially, slower, span, strictly, subjective, targeting, timeframe, variety, vasculature, vasodilation, volume, withBurkholderia, Yale
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.51 Form of Performance Share Award Agreement Used Under the 2004 Equity Incentive Plan (for Grants to Certain Executive Officers Made In 2012)
- 10.62 Gilead Sciences, Inc. Severance Plan, As Amended on January 26, 2012
- 31.1 Certification of Chief Executive Officer, As Required by Rule 13A-14(A) or Rule 15D-14(A) of the Securities Exchange Act of 1934, As Amended
- 31.2 Certification of Chief Financial Officer, As Required by Rule 13A-14(A) or Rule 15D-14(A) of the Securities Exchange Act of 1934, As Amended
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer, As Required by Rule 13A-14(A) or Rule 15D-14(B) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.s.c. 1350)
Related press release
GILD similar filings
Filing view
External links